961 Preliminary results of a phase 2 study of intratumoral administration of BO-112 with pembrolizumab in patients with advanced melanoma that have progressive disease on anti-PD-1-based therapy

التفاصيل البيبلوغرافية
العنوان: 961 Preliminary results of a phase 2 study of intratumoral administration of BO-112 with pembrolizumab in patients with advanced melanoma that have progressive disease on anti-PD-1-based therapy
المؤلفون: Rodas, Iván Márquez, Saiag, Philippe, Merino, Luis de la Cruz, Dutriaux, Caroline, Rodríguez-Moreno, Juan, Robert, Caroline, Arance, Ana, Álvarez, Eduardo Castañón, Cerezuela-Fuentes, Pablo, Montaudie, Henry, Sanmamed, Miguel, Cao, María González, Charles, Julie, López Criado, María Pilar, Berrocal, Alfonso, Miguel, Enrique de, Funk-Brentano, Elisa, Prey, Sorilla, Huertas, Roberto, Abreu, Delvys Rodríguez, Couselo, Eva Muñoz, Martin-Liberal, Juan, López, Javier Sánchez, Escuin-Ordinas, Helena, Quintero, Marisol, Maciá, Sonia, Chaney, Marya, Dalle, Stephane
المصدر: Late-Breaking Abstracts
بيانات النشر: BMJ Publishing Group Ltd
سنة النشر: 2021
نوع الوثيقة: conference object
اللغة: unknown
DOI: 10.1136/jitc-2021-sitc2021.961
DOI: 10.1136/jitc-2021-SITC2021.961
الإتاحة: https://doi.org/10.1136/jitc-2021-sitc2021.961Test
رقم الانضمام: edsbas.3F41EC97
قاعدة البيانات: BASE